

Unithiol - complexing agent, has a detoxification effect.
The active sulfhydryl groups of Unithiol, interacting with thiol poisons (arsenic compounds, salts of heavy metals) and forming non-toxic water-soluble compounds with them, restore the functions of the enzyme systems of the body affected by poison.
Increases the elimination of certain cations (especially copper and zinc) from metal-containing cell enzymes.
Pharmacokinetics
When administered parenterally rapidly absorbed into the blood. The maximum concentration of the drug in the blood (Cmax) is achieved in 15-30 minutes after intramuscular injection.
The half-life (T1 / 2) is 1-2 hours.
The volume of distribution is 166.5 ml / kg. The drug is distributed mainly in the aqueous phase (blood plasma). Not cumulated.
Excreted by the kidneys, mainly in the form of products of incomplete and complete oxidation, partially in unchanged form.
1 ml solution for intramuscular and subcutaneous administration contains:
active ingredients: sodium dimercaptopropanesulfonate monohydrate (unithiol) 50 mg;
excipients: disodium edetate (Trilon B), sulfuric acid 0.1 M (to pH 3.1-4.5), water d / u.
No customer reviews for the moment.
Unithiol is used primarily intramuscularly or subcutaneously.
The simultaneous use of Unithiol with drugs that include heavy metals and alkalis is not recommended, as Uniol is rapidly decomposed.
Contraindicated in pregnancy and lactation.
In case of acute poisoning, additional therapeutic measures are performed (gastric lavage, oxygen therapy, administration of dextrose, etc.).
Symptoms: shortness of breath, hyperkinesis, lethargy, lethargy, stupor, short-term seizures (occur when the recommended therapeutic dose is exceeded by more than 10 times).
Treatment: symptomatic therapy.
Studies and clinical trials of Unithiol (Click to expand)